Clinical trials: Low or Intermediate Risk Prostate Cancer
Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
This prospective study assess the effectiveness and safety of hypofractionated proton radiotherapy in the treatment of intermediate and low risk prostate cancer.
- Trial name
- NCT03740191
- Testing
- EPIC questionnaire, kV x-ray images, Conebeam CT
- Where
- Austria
- Volunteers
- 5 people
- Sponsor
- EBG MedAustron GmbH
Localized Low-Intermediate Risk Prostate Cancer
Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study
The hypothesis of this feasibility study is that focal treatment with ExAblate MRgFUS has the potential to be a safe and effective non-invasive treatment for low to intermediate risk, organ-confined prostate cancer involving low…
- Trial name
- NCT01226576
- Testing
- MRgFUS Treatment
- Where
- 5 sites in Canada, Israel and 3 more
- Volunteers
- 8 people
- Sponsor
- InSightec